US Cardiac Implants Market

US Cardiac Implants Market

US demand to reach $16.4 billion in 2012
US demand for cardiac implants will increase 8.8 percent annually to $16.4 billion in 2012. Evolving demographic and epidemiological patterns, along with the introduction of new and improved products, will promote growth. Based on aging population trends, the number of persons afflicted with one or more heart conditions is forecast to reach 73 million in 2012, up 1.7 percent per year from 2007. Implants are more effective than pharmaceuticals in treating, managing or preventing such cardiovascular disorders as arrhythmias, congestive heart failure, myocardial infarction, peripheral artery disease, stroke and valvular heart disease.

The market for cardiac implants is expected to recover from a sharp decline in coronary drug-eluting stent sales that began in mid-2006 and continued into the fourth quarter of 2007. This decline was due to a number of reports that linked the devices to a slightly greater risk of thrombosis in some post-angioplasty patients. Although the reported risk was only onehalf of one percent greater than for heart patients who received alternative therapies (i.e., angioplasty with bare-metal stents, coronary bypass surgery, medications), it prompted many physicians to discontinue using drug-eluting stents. This trend will change as new generation drug-eluting stents with smaller struts and a greatly reduced risk of complications reach the market over the next year.

Please Note: Freedonia requires that, for PDF orders, clients sign a confidentiality agreement prior to fulfillment of PDF email delivery. 
 

INTRODUCTION

I. EXECUTIVE SUMMARY

II. MARKET ENVIRONMENT

General

Macroeconomic Trends

Demographic Patterns

Health Insurance Trends

Medical Conditions

Acute Conditions

Chronic Conditions

National Health Expenditures

Medical Providers

Acute Care Hospitals

Outpatient Clinics

Skilled Nursing Homes

Physicians

Home Health Care Organizations

Patient Activity

Acute Care Hospital Admissions

Surgical Procedures

Outpatient Episodes

Home Health Care Visits

Medical Product Markets

III. CARDIAC IMPLANT OVERVIEW

General

Cardiovascular Conditions

Coronary Heart Disease

Heart Rhythm Disorders

Peripheral Arterial Disease (PAD)

Valvular Heart Disease

Stroke

Congestive Heart Failure (CHF)

Congenital Heart Defects

Cardiac Implant Procedures

Cardiac Implant Market Trends

Regulatory Factors

Demand Patterns

Product Groups

Indications

US Trade

International Markets

IV. PACING DEVICES

General

Demand Patterns & Projections

Producers & Market Share

Implantable Cardioverter Defibrillators (ICDs)

Technology

Components & Design

Functions

Clinical Data

Producers & Products

Medtronic

Boston Scientific

St. Jude Medical

Cardiac Resynchronization Therapy (CRT) Devices

Technology

Producers & Products

Implantable Cardiac Pacemakers (ICPs)

Technology

Producers & Products

Medtronic

St. Jude Medical

Boston Scientific

Pacing Leads

Technology

Producers & Products

Pacemaker Leads

ICD Leads

CRT Leads

Pacing Device Batteries

V. CARDIAC STENTS & RELATED IMPLANTS

General

Demand Patterns & Projections

Producers & Market Share

Coronary Stents

Drug-Eluting Stents

Bare-Metal Stents

Peripheral Stents

Endovascular Stent-Grafts

Medtronic

ANCURE

Other Endovascular Stent-Grafts

Renal & Related Stents

Femoral & Related Stents

Carotid Stents

Stent-Related Implants

Synthetic Grafts

Vascular Grafts

Peripheral Grafts

Vena Cava Filters

VI. STRUCTURAL CARDIAC IMPLANTS

General

Demand Patterns & Projections

Producers & Market Share

Heart Valves & Accessories

Product Overview

Tissue Heart Valves

Types of Tissue Heart Valves

Producers & Products

Mechanical Heart Valves

Design

Producers & Products

Heart Valve Repair Products

Ventricular-Assist Devices

Technology

Producers & Products

Implantable Heart Monitors

Insertable Loop Recorders (ILRs)

Implantable Hemodynamic Monitors

VII. INDUSTRY STRUCTURE

General

Market Share

Competitive Strategies

Mergers & Acquisitions

Licensing & Related Agreements

Research & Development

Marketing & Distribution

Manufacturing Activities

Company Profiles

Abbott Laboratories

Abiomed Incorporated

Angiotech Pharmaceuticals Incorporated

Arbor Surgical Technologies Incorporated

Bard (CR) Incorporated

Biophan Technologies Incorporated

Boston Scientific Corporation

Braun (B.) Melsungen AG

CarboMedics Incorporated, see Sorin SpA

Conor Medsystems LLC, see Johnson & Johnson

Cook Group Incorporated

Cordis Corporation, see Johnson & Johnson

Core Valve Incorporated

Edwards Lifesciences Corporation

Endologix Incorporated

Gore (WL) & Associates Incorporated

Johnson & Johnson

Medtronic Incorporated

Myotech LLC, see Biophan Technologies Incorporated

Sorin SpA

St. Jude Medical Incorporated

Terumo Corporation

Thoratec Corporation

Ventracor Limited

LIST OF TABLES

SECTION I -- EXECUTIVE SUMMARY

Summary Table

SECTION II -- MARKET ENVIRONMENT

1 Macroeconomic Indicators

2 Population by Age Group

3 Health Insurance Coverage of the US Population

4 Acute Conditions by Type

5 Chronic Conditions by Type

6 National Health Expenditures by Type & Source

7 Medical Providers by Type

8 Patient Activity by Type

9 Medical Product Demand

SECTION III -- CARDIAC IMPLANT OVERVIEW

1 Cardiac Implant Market Indicators

2 Cardiovascular Conditions by Type

3 Cardiac Implant Procedures by Type

4 Cardiac Implant Market, 1997-2007

5 Cardiac Implant Demand by Product Group

6 Cardiac Implant Demand by Indication

7 US Trade in Cardiac Implants

8 World Cardiac Implant Demand by Region

SECTION IV -- PACING DEVICES

1 Pacing Device Demand by Product Group

2 Implantable Cardioverter Defibrillator (ICD) Demand by Type

3 Cardiac Resynchronization Therapy (CRT) Device Demand

4 Implantable Cardiac Pacemaker Demand by Type

5 Pacing Lead Demand by Type

SECTION V -- STENTS & RELATED IMPLANTS

1 Cardiac Stent & Related Implant Demand by Product Group

2 Coronary Stent Demand by Type

3 Coronary Drug-Eluting Stent Demand

4 Coronary Bare-Metal Stent Demand

5 Peripheral Stent Demand by Product Group

6 Endovascular Stent-Graft Demand

7 Renal & Related Stent Demand

8 Femoral & Related Stent Demand

9 Carotid Stent Demand

10 Stent-Related Implant Demand by Product Group

SECTION VI -- STRUCTURAL CARDIAC IMPLANTS

1 Structural Cardiac Implant Demand by Product Group

2 Heart Valve Implant Demand by Product Group

3 Ventricular Assist Device Demand

4 Implantable Heart Monitor Demand

SECTION VII -- INDUSTRY STRUCTURE

1 Cardiac Implant Sales by Company, 2007

2 Selected Acquisitions & Divestitures

3 Selected Cooperative Agreements

LIST OF CHARTS

SECTION III -- CARDIAC IMPLANT OVERVIEW

1 Cardiovascular Conditions by Type, 2007

2 Cardiac Implant Procedures by Type, 2007

3 Cardiac Implant Demand by Product Group, 2007

4 Cardiac Implant Demand by Indication, 2007

SECTION IV -- PACING DEVICES

1 Pacing Device Demand by Product Group, 2007

2 Pacing Devices Market Share by Company, 2007

SECTION V -- STENTS & RELATED IMPLANTS

1 Stent & Stent-Related Implant Demand by Product Group, 2007

2 Stents & Stent-Related Implant Market Share by Company, 2007

SECTION VI -- STRUCTURAL CARDIAC IMPLANTS

1 Structural Cardiac Implant Demand by Product Group, 2007

2 Structural Cardiac Implant Market Share by Company, 2007

SECTION VII -- INDUSTRY STRUCTURE

1 US Cardiac Implants, Market Share by Company, 2007

 
 

---

More Details

ICDs, CRT devices will remain dominant types
Cardiac implants extend into several product groups. Implantable cardioverter defibrillators (ICDs) and related cardiac resynchronization therapy (CRT) devices together with their accessories generate the largest demand, followed by various types of stents. These two product groups will continue to lead cardiac implant sales based on new product introductions, widening eligibility for private and public health insurance coverage, expanding numbers of new patients, and diminishing safety concerns. Providing the most effective therapy for bradycardia, pacemakers and accessories will continue to serve a large, expanding US market. However, growth opportunities for these devices will decelerate over the long term as they have already achieved a high level of market penetration.

Heart-related grafts will provide strong growth opportunities as improvements in stenting systems create new safe and effective devices for treating aortic aneurysms, peripheral arterial diseases and stroke. Demand for heart valves will benefit from advances in tissue engineering, which will improve the safety, performance and longevity of animalderived xenografts. Heart valve repair products, consisting of annuloplasty rings and bands, will also fare well in the marketplace as new cardiac diagnostics enable valvular heart diseases to be detected in earlier stages before complete valve replacement becomes necessary. Less favorably, strong growth in the market for tissue valves and valve repair products will be partially offset by decreasing sales of mechanical valves.

Demand for embolic protection devices will rise at a strong pace as many more heart patients undergo procedures that pose an elevated risk of deep vein thrombosis and embolisms. The market for ventricular-assist devices will continue to grow moderately, spurred by widening applications in the management of pretransplant and late-stage heart conditions. Based on their ability to detect heart attack symptoms earlier and save lives, implantable heart monitors will register strong sales growth over the long term.

Study coverage
Cardiac Implants is a new Freedonia industry study available for $4500. It presents historical demand data (1997, 2002, 2007) plus forecasts for 2012 and 2017 for cardiac implant products by type and indication. The study also assesses evolving research and development, details company market shares and profiles 20 competitors in the US industry.